Pro-active Genetic Testing in Kidney Transplant Patients

See also
Status	Clinical Trial	Phase
Completed	`NCT04087720` - Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant	Phase 4
Completed	`NCT03749356` - Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients	Phase 4
Withdrawn	`NCT05811468` - Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients
Completed	`NCT03527238` - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine	Phase 2
Completed	`NCT00498576` - Melatonin and Adiponectin in Hypertensive Kidney Transplant	N/A
Completed	`NCT00642655` - Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation	Phase 1/Phase 2
Completed	`NCT00374400` - The Paired Donation Consortium Paired Donation Program	N/A
Completed	`NCT01710033` - A Study Of CP-690,550 In Stable Kidney Transplant Patients	Phase 1
Completed	`NCT00205257` - Prediction of Acute Rejection in Renal Transplant	Phase 1
Completed	`NCT02711826` - Treg Therapy in Subclinical Inflammation in Kidney Transplantation	Phase 1/Phase 2
Withdrawn	`NCT03978494` - Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.	Phase 1
Completed	`NCT03837522` - Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies	N/A
Not yet recruiting	`NCT06025240` - Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Completed	`NCT05029310` - Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients	Phase 4
Completed	`NCT03644485` - Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients	Phase 4
Active, not recruiting	`NCT02409901` - Effects of Personalized Physical Rehabilitation in Kidney Transplant Recipients	N/A
Completed	`NCT01047410` - ACtive Care After Transplantation, the ACT Study	N/A
Completed	`NCT00940940` - Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation	Phase 4
Completed	`NCT00217126` - The Study of Long-term Deterioration of Kidney Transplants.	Phase 4
Completed	`NCT00270712` - A Study of Factors That Affect Long-Term Kidney Transplant Function

NCT number	NCT05298904
Study type	Observational
Source	Mayo Clinic
Contact
Status	Active, not recruiting
Phase
Start date	March 28, 2022
Completion date	March 1, 2038

Pro-active Genetic Testing in Kidney Transplant Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms